The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.Candace A. Beck, Dean P. Edwards, Nancy L. Weigel et al.|Proceedings of the National Academy of Sciences|1993Cited by 210
Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.Candace A. Beck, Dean P. Edwards, Nancy L. Weigel|Molecular Endocrinology|1992Cited by 115
Phosphorylation of Human Progesterone Receptor by Cyclin-Dependent Kinase 2 on Three Sites That Are Authentic Basal Phosphorylation Sites<i>In Vivo</i>Yixian Zhang, Nancy L. Weigel, Candace A. Beck et al.|Molecular Endocrinology|1997Cited by 95
Progesterone receptor and the mechanism of action of progesterone antagonistsDean P. Edwards, Candace A. Beck, Magda Altmann et al.|The Journal of Steroid Biochemistry and Molecular Biology|1995Cited by 85
Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II.Yixian Zhang, Nancy L. Weigel, Candace A. Beck et al.|Journal of Biological Chemistry|1994Cited by 82